PAROKIN 37.5CR

Product Description

PAROKIN CR 37.5 Tablet is classified as a selective serotonin reuptake inhibitor (SSRI), a category of antidepressants. This medication is commonly prescribed for the management of various mood disorders, including depression and anxiety disorders such as obsessive-compulsive disorder and panic disorder. The primary function of PAROKIN CR 37.5 Tablet is to enhance mood and alleviate symptoms of anxiety and stress, thereby supporting individuals in their recovery from depressive episodes. The administration of this tablet can be done either with meals or on an empty stomach, based on individual preferences or medical advice. It is essential for patients to adhere to the dosage and frequency prescribed by their healthcare provider to ensure effective symptom control. Physicians may initiate treatment with a lower dosage, gradually increasing it as needed. It is critical not to modify the prescribed dosage or discontinue usage without consulting a healthcare professional, even if the patient feels an improvement in their condition. Abrupt changes in dosage can exacerbate symptoms or trigger withdrawal effects such as anxiety, restlessness, and sleep issues. For optimal results, it is advisable to take the medication consistently at the same time each day, with morning doses recommended for those experiencing sleep disturbances. Patients should be aware that it may take several weeks to notice an improvement in their symptoms. If no progress is observed after four weeks of treatment, it is important to communicate this with the healthcare provider. Additionally, individuals should notify their doctor if there is a sudden decline in mood or any thoughts of self-harm. It is also vital to disclose any underlying health conditions, particularly epilepsy, diabetes, liver or kidney issues, heart diseases, or glaucoma, prior to starting the medication to avoid complications. Pregnant or nursing individuals are advised to seek medical guidance before commencing treatment with this tablet, as interactions with other medications, especially certain antidepressants and MAO inhibitors, could impact its effectiveness and safety.